![cover image](https://wikiwandv2-19431.kxcdn.com/_next/image?url=https://upload.wikimedia.org/wikipedia/commons/thumb/4/45/Parecoxib.svg/640px-Parecoxib.svg.png&w=640&q=50)
Parecoxib
Type of nonsteroidal anti-inflammatory drug / From Wikipedia, the free encyclopedia
For the "dynastat" type of hybrid airship, see Hybrid airship.
Parecoxib, sold under the brand name Dynastat among others, is a water-soluble and injectable prodrug of valdecoxib. Parecoxib is a COX2 selective inhibitor. It is injectable. It is approved in the European Union for short term perioperative pain control.
Quick Facts Clinical data, AHFS/Drugs.com ...
![]() | |
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
Pregnancy category |
|
Routes of administration | Intravenous, intramuscular |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 100% |
Protein binding | 98% |
Metabolism | Liver to valdecoxib and propionic acid CYP extensively involved (mainly CYP3A4 and 2C9) |
Elimination half-life | 22 minutes (parecoxib) 8 hours (valdecoxib) |
Excretion | Kidney (70%, metabolites) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank |
|
ChemSpider |
|
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.230.078 ![]() |
Chemical and physical data | |
Formula | C19H18N2O4S |
Molar mass | 370.42 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Close
It was patented in 1996 and approved for medical use in 2002.[3]